Skip to main content

Articles

3909 result(s) for 'lung cancer prognosis stage 4' within BMC Cancer

Page 34 of 79

  1. Triple negative breast cancer (TNBC) is clinically aggressive breast cancer with a poor prognosis. Approximately 20% of TNBC has been found to express programmed death ligand 1 (PD-L1), making it a potential t...

    Authors: K. Sharmni Vishnu, Thin Thin Win, Saint Nway Aye and Arun Kumar Basavaraj
    Citation: BMC Cancer 2022 22:1139
  2. Despite the widespread availability of medication choices for metastatic castration-resistant prostate cancer (mCRPC), biomarkers to predict the efficacy of each mCRPC treatment have not yet been established. ...

    Authors: Takashi Kawahara, Yusuke Saigusa, Shuko Yoneyama, Masashi Kato, Ippei Kojima, Hiroshi Yamada, Osamu Kamihira, Kenichi Tabata, Hideyasu Tsumura, Masatsugu Iwamura, Kazuhide Makiyama, Hiroji Uemura and Yasuhide Miyoshi
    Citation: BMC Cancer 2023 23:214
  3. The prognostic values of preoperative aspartate aminotransferase (AST), monocyte-to-lymphocyte ratio (MLR), AST·MLR index (AMLRI) and operation injury condition in patients with colorectal cancer liver metasta...

    Authors: Qichen Chen, Mingxia Li, Jinghua Chen, Zhen Huang, Xiao Chen, Hong Zhao and Jianqiang Cai
    Citation: BMC Cancer 2022 22:921
  4. PPFIA1 is an important regulator of cell migration and invasion, regulating focal adhesion signalling and disassembly. PPFIA1 is frequently amplified in breast cancer, and recent functional studies indicate th...

    Authors: Lutfi H. Alfarsi, Rokaya El Ansari, Madeleine L. Craze, Brendah K. Masisi, Ian O. Ellis, Emad A. Rakha and Andrew R. Green
    Citation: BMC Cancer 2020 20:425
  5. Luminal B cancers show much worse outcomes compared to luminal A. This present study aims to screen key lncRNAs and mRNAs correlated with luminal-B breast cancer.

    Authors: Cheng-Liang Yuan, Xiang-Mei Jiang, Ying Yi, Jian-Fei E, Nai-Dan Zhang, Xue Luo, Ning Zou, Wei Wei and Ying-Ying Liu
    Citation: BMC Cancer 2019 19:1171
  6. Versican is detected in the interstitial tissues at the invasive margins of breast carcinoma, is predictive of relapse, and negatively impacts overall survival rates. The versican G3 domain is important in bre...

    Authors: William Weidong Du, Ling Fang, Weining Yang, Wang Sheng, Yaou Zhang, Arun Seth, Burton B Yang and Albert J Yee
    Citation: BMC Cancer 2012 12:341
  7. The transcription factor nuclear factor (erythroid-2)–related factor 2 (Nrf2) was originally identified as a critical regulator of intracellular anti-oxidants and of phase II detoxification enzymes through its...

    Authors: Yota Kawasaki, Sumiya Ishigami, Takaaki Arigami, Yoshikazu Uenosono, Shigehiro Yanagita, Yasuto Uchikado, Yoshiaki Kita, Yuka Nishizono, Hiroshi Okumura, Akihiro Nakajo, Yuko Kijima, Kosei Maemura and Shoji Natsugoe
    Citation: BMC Cancer 2015 15:5
  8. Posttranscriptional protein modification by SUMOylation plays an important role in tumor development and progression. In the current study we analyzed prevalence and prognostic impact of the de-SUMOylation enz...

    Authors: Christoph Burdelski, Devi Menan, Maria Christina Tsourlakis, Martina Kluth, Claudia Hube-Magg, Nathaniel Melling, Sarah Minner, Christina Koop, Markus Graefen, Hans Heinzer, Corinna Wittmer, Guido Sauter, Ronald Simon, Thorsten Schlomm, Stefan Steurer and Till Krech
    Citation: BMC Cancer 2015 15:538
  9. Renal cell carcinoma (RCC) is marked by high mortality rate. To date, no robust risk stratification by clinical or molecular prognosticators of cancer-specific survival (CSS) has been established for early sta...

    Authors: Daniel Vergho, Susanne Kneitz, Andreas Rosenwald, Charlotte Scherer, Martin Spahn, Maximilian Burger, Hubertus Riedmiller and Burkhard Kneitz
    Citation: BMC Cancer 2014 14:25
  10. Microsatellite instability-high (MSI-H) has emerged as a significant biological characteristic of colorectal cancer (CRC). Studies reported that MSI-H CRC generally had a better prognosis than microsatellite s...

    Authors: Junwen Cai, Yuting Yang, Leilei Zhang, Yangyang Fang, Yanjun Zhang, Mingyue Tan, Juan Zhang, Chen Tang, Haitao Ren, Lanni Wang, Guangxin Xiang, Feng Xu, Linhua Lan, Liyi Li and Xiaoqun Zheng
    Citation: BMC Cancer 2024 24:573
  11. Dramatic weight loss is an often underestimated symptom in pancreatic cancer patients. Cachexia- defined as an unintended loss of stable weight exceeding 10% – is present in up to 80% of patients with cancer o...

    Authors: Jeannine Bachmann, Knut Ketterer, Christiane Marsch, Kerstin Fechtner, Holger Krakowski-Roosen, Markus W Büchler, Helmut Friess and Marc E Martignoni
    Citation: BMC Cancer 2009 9:255
  12. Ovarian cancer (OC) is the most lethal gynecological cancer due to the recurrence of drug-resistance. Cancer initiating cells (CICs) are proposed to be responsible for the aggressiveness of OC. The rarity and ...

    Authors: Yu-An Chen, Chen-Yu Lu, Wen-Fang Cheng, Kuan-Ting Kuo, Chen-Wei Yu, Hon-Nerng Ho, Hsin-Fu Chen and Szu-Hua Pan
    Citation: BMC Cancer 2022 22:967
  13. Despite recent advances in the treatments of hepatocellular carcinoma (HCC), the prognosis of HCC patients remains controversial. The purpose of this study was to investigate the prognostic performance of pret...

    Authors: Mian-Tao Wu, Su-Yin He, Shu-Lin Chen, Lin-Fang Li, Zheng-Qiang He, Yuan-Ying Zhu, Xia He and Hao Chen
    Citation: BMC Cancer 2019 19:538
  14. Despite much effort on the treatment of breast cancer over the decades, a great uncertainty regarding the appropriate molecular biomarkers and optimal therapeutic strategy still exists. This research was perfo...

    Authors: Chenjing Zhu, Otilia Menyhart, Balázs Győrffy and Xia He
    Citation: BMC Cancer 2019 19:1046
  15. In cancer research the selection and definitions of survival endpoints are important and yet they are not used consistently. The aim of this study was to compare different survival endpoints in patients with p...

    Authors: Helgi Birgisson, Ulrik Wallin, Lars Holmberg and Bengt Glimelius
    Citation: BMC Cancer 2011 11:438
  16. Non-small cell lung cancer is the most common cause of cancer death worldwide, highlighting the need for novel therapeutic concepts. In particular, there is still a lack of treatment strategies for the group o...

    Authors: Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brückner, Daniel Wilhelm Mueller, Michael Thomas and Stefan Rieken
    Citation: BMC Cancer 2020 20:806

    The Correction to this article has been published in BMC Cancer 2023 23:740

  17. The investigational oral DNA vaccine VXM01 targets the vascular endothelial growth factor receptor 2 (VEGFR-2) and uses Salmonella typhi Ty21a as a vector. The immune reaction elicited by VXM01 is expected to dis...

    Authors: Andreas G Niethammer, Heinz Lubenau, Gerd Mikus, Philipp Knebel, Nicolas Hohmann, Christine Leowardi, Philipp Beckhove, Mustafa Akhisaroglu, Yingzi Ge, Marco Springer, Lars Grenacher, Markus W Buchler, Moritz Koch, Jürgen Weitz, Walter E Haefeli and Friedrich H Schmitz-Winnenthal
    Citation: BMC Cancer 2012 12:361
  18. Breast cancer (BC) with low human epidermal growth factor receptor 2 (HER2) expression is attracting much attention due to the breakthrough progress of novel anti-HER2 antibody-drug conjugates. HER2 expression...

    Authors: Mengyuan Cai, Ming Li, Hong Lv, Shuling Zhou, Xiaoli Xu, Ruohong Shui and Wentao Yang
    Citation: BMC Cancer 2023 23:656
  19. Lymphangiogenesis plays a significant role in metastasis and recurrence of gastric cancer. There is no report yet focusing on the modulation of VEGF pathway and lymphangiogenesis of gastric cancer by targeting...

    Authors: Hongxia Chen, Runnian Guan, Yupeng Lei, Jianyong Chen, Qi Ge, Xiaoshen Zhang, Ruoxu Dou, Hongyuan Chen, Hao Liu, Xiaolong Qi, Xiaodong Zhou and Changyan Chen
    Citation: BMC Cancer 2015 15:103
  20. Large-scale genomic alterations, especially CD274/PD-L1 gene amplification, have great impact on anti-PD-1 efficacy on cancers such as Hodgkin’s lymphoma. However, the prevalence of PD-L1 genetic alterations i...

    Authors: Lin Yang, Shousheng Liu, Wenzhuo He, Zhenchong Xiong and Liangping Xia
    Citation: BMC Cancer 2023 23:221
  21. Endometrial cancer (EC) is the most common malignancy of the female reproductive tract. Despite years of research, the accurate screening strategy is still not available in this disease and it is usually diagn...

    Authors: Anna Torres, Małgorzata Pac-Sosińska, Krzysztof Wiktor, Tomasz Paszkowski, Ryszard Maciejewski and Kamil Torres
    Citation: BMC Cancer 2019 19:401
  22. Transarterial chemoembolization (TACE) is the standard treatment for intermediate stage hepatocellular carcinoma (HCC) (Barcelona Clinic Liver Cancer [BCLC] B). However, it often leads to a poor prognosis and ...

    Authors: Satoshi Kobayashi, Taito Fukushima, Makoto Ueno, Satoshi Moriya, Makoto Chuma, Kazushi Numata, Kota Tsuruya, Shunji Hirose, Tatehiro Kagawa, Nobuhiro Hattori, Tsunamasa Watanabe, Kotaro Matsunaga, Michihiro Suzuki, Haruki Uojima, Hisashi Hidaka, Chika Kusano…
    Citation: BMC Cancer 2022 22:517
  23. This study aimed to report the prevalence of HER2-neu in newly diagnosed early or metastatic gastric cancer (GC) patients, to determine the percentage of patients achieving various IHC scores correlating with ...

    Authors: Joseph Kattan, Fady el Karak, Fadi Farhat, Dany Abi Gerges, Walid Mokaddem, Georges Chahine, Saad Khairallah, Najla Fakhruddin, Jawad Makarem and Fadi Nasr
    Citation: BMC Cancer 2022 22:1114
  24. At present pathogenic mechanisms of cancer cachexia are poorly understood. Previous evidence in animal models implicates the melanocortin-4 receptor gene (MC4R) in the development of cancer cachexia. In humans, M...

    Authors: Susanne Knoll, Sabiene Zimmer, Anke Hinney, André Scherag, Andreas Neubauer and Johannes Hebebrand
    Citation: BMC Cancer 2008 8:85
  25. In our previous study, colorectal cancer (CRC) patients with active Mycobacterium tuberculosis (MTB) tolerated concurrent anti-cancer chemotherapy (anti-CCT) and anti-MTB chemotherapy. In this study, we retrospec...

    Authors: Tomonori Hirashima, Yoshitaka Tamura, Yuki Han, Shoji Hashimoto, Ayako Tanaka, Takayuki Shiroyama, Naoko Morishita, Hidekazu Suzuki, Norio Okamoto, Shinobu Akada, Makoto Fujishima, Yoshihisa Kadota, Kazuya Sakata, Akiko Nishitani, Satoru Miyazaki and Takayuki Nagai
    Citation: BMC Cancer 2018 18:975
  26. Ovarian cancer is one of the most common gynecological malignancies due to the lack of early symptoms, early diagnosis and limited screening. Therefore, it is necessary to understand the molecular mechanism un...

    Authors: Gendi Song, Zhengwei Sun, Man Chu, Zihan Zhang, Jiajia Chen, Zhiwei Wang and Xueqiong Zhu
    Citation: BMC Cancer 2024 24:122
  27. Tumor hypoxia is associated with prostate cancer (PCa) treatment resistance and poor prognosis. Pimonidazole (PIMO) is an investigational hypoxia probe used in clinical trials. A better understanding of the cl...

    Authors: Xinpei Ci, Sujun Chen, Rui Zhu, Mojgan Zarif, Rahi Jain, Wangyuan Guo, Matthew Ramotar, Linsey Gong, Wenjie Xu, Olivia Singh, Sheila Mansouri, Gelareh Zadeh, Gong-Hong Wei, Wei Xu, Robert Bristow, Alejandro Berlin…
    Citation: BMC Cancer 2024 24:744
  28. The viral pandemic coronavirus disease 2019 (COVID-19) has disrupted cancer patient management around the world. Most reported data relate to incidence, risk factors, and outcome of severe COVID-19. The safety...

    Authors: C. van Marcke, N. Honoré, A. van der Elst, S. Beyaert, F. Derouane, C. Dumont, F. Aboubakar Nana, J. F. Baurain, I. Borbath, P. Collard, F. Cornélis, A. De Cuyper, F. P. Duhoux, B. Filleul, R. Galot, M. Gizzi…
    Citation: BMC Cancer 2021 21:578
  29. The prognosis of patients with recurrent, platinum-resistant epithelial ovarian cancer (EOC) is poor. There is no standard treatment available. Emerging evidence suggests a major role for antiangiogenic treatm...

    Authors: Michael Eichbaum, Christine Mayer, Regina Eickhoff, Esther Bischofs, Gerhard Gebauer, Tanja Fehm, Florian Lenz, Hans-Christian Fricke, Erich Solomayer, Nikos Fersis, Marcus Schmidt, Markus Wallwiener, Andreas Schneeweiss and Christof Sohn
    Citation: BMC Cancer 2011 11:453
  30. Although chromosomal instability (CIN) has been detected in many kinds of human malignancies by means of various methods, there is no practical assessment for small clinical specimens. In this study, we evalua...

    Authors: Hiroaki Sato, Narikazu Uzawa, Ken-Ichiro Takahashi, Kunihiro Myo, Yoshio Ohyama and Teruo Amagasa
    Citation: BMC Cancer 2010 10:182
  31. Lymph node metastasis (LNM) is a critical event during the colorectal cancer (CRC) development and is indicative of poor prognosis. Identification of molecular markers of LNM may facilitate better therapeutic ...

    Authors: Chengxing Wang, Bin Wang, Weijun Liang, Chaorong Zhou, Weixing Lin, Zijie Meng, Wanting Wu, Meimei Wu, Yuehua Liao, Xiaoping Li, Jinglin Zhao and Yaoming He
    Citation: BMC Cancer 2022 22:922
  32. Hepatocellular carcinoma (HCC) is the most common type of malignant liver tumor with poor prognosis. In this study, we investigated the expression of transforming growth factor beta regulator 4 (TBRG4) in HCC ...

    Authors: Shanchun Tao, Di Cui, Huimin Cheng, Xiaofei Liu, Zhaobin Jiang, Hongwei Chen and Yong Gao
    Citation: BMC Cancer 2024 24:194
  33. To compare the diagnostic performance of the Node-RADS scoring system and lymph node (LN) size in preoperative LN assessment for rectal cancer (RC), and to investigate whether the selection of size as the prim...

    Authors: Yue Niu, Lu Wen, Yanhui Yang, Yi Zhang, Yi Fu, Qiang Lu, Yu Wang, Xiao Yu and Xiaoping Yu
    Citation: BMC Cancer 2024 24:716
  34. Our study aims to explore the relationship, shared gene signature, and the underlying mechanisms that connect rheumatoid arthritis (RA) to colorectal cancer (CRC).

    Authors: Zhi-Qing Zhan, Ze-Min Huang, Qi-Wen Lan, Yu-Hua Luo, Jia-Xin Li, Ya-Fang Zheng, Ying-Zhou Chen, Pei-Zhen Chen, Tian-Ye Luo, Baoqing Sun and Zhangkai J Cheng
    Citation: BMC Cancer 2024 24:714
  35. The presence of circulating cell-free DNA from tumours in blood (ctDNA) is of major importance to those interested in early cancer detection, as well as to those wishing to monitor tumour progression or diagno...

    Authors: Ian A. Cree, Lesley Uttley, Helen Buckley Woods, Hugh Kikuchi, Anne Reiman, Susan Harnan, Becky L. Whiteman, Sian Taylor Philips, Michael Messenger, Angela Cox, Dawn Teare, Orla Sheils and Jacqui Shaw
    Citation: BMC Cancer 2017 17:697
  36. Dicer is aberrantly expressed in several types of cancers. Applying real-time PCR, we detected the expression of Dicer mRNA in normal mucosa (n = 162), primary colorectal cancer (CRC) (n = 162) and liver metas...

    Authors: Johannes Stratmann, Chao-Jie Wang, Sebastian Gnosa, Ã…sa Wallin, David Hinselwood, Xiao-Feng Sun and Hong Zhang
    Citation: BMC Cancer 2011 11:345
  37. This study aimed to investigate the efficacy and safety of cytokine-induced killer (CIK)/dendritic cell combined with CIK (DC–CIK) cell therapy in advanced gastrointestinal cancer (GIC).

    Authors: Hansong Du, Jia Yang and Ying Zhang
    Citation: BMC Cancer 2020 20:357
  38. T-lymphoma invasion and metastasis-inducing protein 1 (Tiam1) has been implicated in tumor occurrence and progression. Recent studies have shown that high expression levels of Tiam1 protein appear to be associ...

    Authors: Zhenling Li, Qixiang Liu, Junjie Piao, Fenjian Hua, Jing Wang, Guang Jin, Zhenhua Lin and Yan Zhang
    Citation: BMC Cancer 2016 16:681
  39. Histological grade has been demonstrated to be an important factor of breast cancer outcome and is associated with cell differentiation and is currently being evaluated via H&E-stained sections. Molecular biom...

    Authors: Mei Li, Yanan Zheng, Xujun Li, Xiaohan Shen, Tingxia Zhang, Bowen Weng, Haijiao Mao and Jiyuan Zhao
    Citation: BMC Cancer 2022 22:1280
  40. Obesity and other metabolic comorbidities affect over 10% of patients with breast cancer and are closely related with adverse outcomes. Although metabolic comorbidities among breast cancer patients in low- and...

    Authors: Sumadi Lukman Anwar, Roby Cahyono, Dayat Prabowo, Widya Surya Avanti, Lina Choridah, Ery Kus Dwianingsih, Wirsma Arif Harahap and Teguh Aryandono
    Citation: BMC Cancer 2021 21:590
  41. Breast cancer (BC) is a malignant tumor that occurs in the epithelial tissue of the breast gland. Long non-coding RNA (lncRNA) small nucleolar RNA host gene 3 (SNHG3) has been found to promote BC cell prolifer...

    Authors: Hongnan Jiang, Xiaojun Li, Wei Wang and Honglin Dong
    Citation: BMC Cancer 2020 20:838
  42. Breast cancer is one of the common malignancies in women. Evidence has demonstrated that FBXO45 plays a pivotal role in oncogenesis and progression. However, the role of FBXO45 in breast tumorigenesis remains ...

    Authors: Mengmeng Zheng, Linfeng Wu, Rongyao Xiao, Jiaohao Cai, Weike Chen and Shurong Shen
    Citation: BMC Cancer 2024 24:619
  43. Osteopontin (OPN) can recruit macrophages to the site of inflammation and promote tumorigenesis. M2 tumor-associated macrophages (M2-TAMs) also play an important role in cancer progression. This study aimed to...

    Authors: Chang-Ni Lin, Chih-Jung Wang, Ying-Jui Chao, Ming-Derg Lai and Yan-Shen Shan
    Citation: BMC Cancer 2015 15:128
  44. The protein AGR2 is a putative member of the protein disulfide isomerase family and was first identified as a homolog of the Xenopus laevis gene XAG-2. AGR2 has been implicated in a number of human cancers. In pa...

    Authors: Erin L Maresh, Vei Mah, Mohammad Alavi, Steve Horvath, Lora Bagryanova, Emily S Liebeskind, Laura A Knutzen, Yong Zhou, David Chia, Alvin Y Liu and Lee Goodglick
    Citation: BMC Cancer 2010 10:680
  45. Macrophage heterogeneity is the main feature of the tumour microenvironment. Breast cancer is one of the most life-threatening cancers. However, macrophage polarization patterns in different tumour stages and ...

    Authors: Chih-Hsing Hung, Fang-Ming Chen, Yi-Ching Lin, Mei-Lan Tsai, Shih-Ling Wang, Yen-Chun Chen, Yi-Ting Chen and Ming-Feng Hou
    Citation: BMC Cancer 2018 18:366
  46. Interleukin-8 (IL-8/CXCL-8) is a prototype of the ELR+CXC chemokines that play an important role in the promotion and progression of many human cancers including breast cancer. We have recently showed the implica...

    Authors: Kaouther Snoussi, Wijden Mahfoudh, Noureddine Bouaouina, Meriem Fekih, Hedi Khairi, Ahmed N Helal and Lotfi Chouchane
    Citation: BMC Cancer 2010 10:283

Featured videos

View featured videos from across the BMC-series journals